RESIST-TB

RESIST-TB April 2022 newsletter

RESIST-TB released its April 2022 newsletter with the latest research publications on drug-resistant TB.

Read More →

Webinar: Treatment of pediatric MDR-TB - lessons from the field

RESIST-TB will host a webinar on 4 May 2022 on the latest childhood treatments and guidelines of the World Health Organization in the pediatric multidrug-resistant TB (MDR-TB) regimens and lessons from the field.

Read More →

Webinar: Discussion of 6-month MDR-TB treatment - recording now available online

RESIST-TB conducted a webinar on 14 April 2022 on the latest results in the recent studies reporting on pretomanid-containing regimens, ZeNiX and TB-PRACTECAL, for the treatment of multidrug-resistant TB (MDR-TB).

Read More →

Webinar: Discussion of 6-month MDR-TB treatment

RESIST-TB will host a webinar on 14 April 2022 on the latest results in the recent studies reporting on pretomanid-containing regimens, ZeNiX and TB-PRACTECAL, for the treatment of multidrug-resistant TB (MDR-TB).

Read More →

RESIST-TB March 2022 newsletter

RESIST-TB released its March 2022 newsletter with the latest research publications on drug-resistant TB.

Read More →

RESIST-TB February 2022 newsletter

RESIST-TB released its February 2022 newsletter with the latest research publications on drug-resistant TB.

Read More →

RESIST-TB January 2022 newsletter

RESIST-TB released its January 2022 newsletter with the latest research publications on drug-resistant TB.

Read More →

RESIST-TB webinar: Pediatric PK for the new and repurposed TB drugs – Where are we now?

RESIST-TB will host a webinar on the latest developments in pediatric pharmacokinetics (PK) of bedaquiline, linezolid, delamanid and pretomanid on 26 January 2022.

Read More →

RESIST-TB December 2021 newsletter

RESIST-TB released its December 2021 newsletter with the latest research publications on drug-resistant TB.

Read More →

RESIST-TB November 2021 newsletter

RESIST-TB released its November 2021 newsletter with the latest research publications on drug-resistant TB.

Read More →

Page 1 of 5 · Total posts: 10

1 2 Last→